U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07039474) titled 'The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy' on May 26.
Brief Summary: The purpose of this study is to explore the effectiveness of 18F-G1 PET/CT in patients with solid tumors and hematological malignancies receiving immunotherapy
Study Start Date: July 15
Study Type: OBSERVATIONAL
Condition:
Solid Tumors and Hematological Tumors
Intervention:
DRUG: 18F-G1
18F-G1 is injected intravenously with a dose of 0.06-0.08mCi/kg
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Peking University First Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....